Literature DB >> 9158089

Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay.

M Macanovic1, P J Lachmann.   

Abstract

A new radial enzyme diffusion (RED) method for the measurement of DNase activity in serum and urine is described. The sensitivity of the assay is in the range of 15.6-500 ng/ml. The assay is based on the hydrolysis of double-stranded (ds) DNA (or nucleosomes) in agarose. The specificity of the reaction for DNase I was established by showing that either EDTA in the reaction buffer or G-actin abolished DNase activity. Being a functional assay, RED has advantages over radioimmunoassay (RIA) or ELISA, since antigenic assays may also measure complexes of DNase with actin. This method was used to measure DNase activity in the sera and urine of lupus-prone mice (NZB/NZW F1 hybrids, aged 4-6 weeks). Serum DNase activity in these mice was significantly lower (mean 9 ng/ml) than in control, normal mice of the same age and sex (mean 37 ng/ml). Concentration of DNase in the urine of 4-6-week-old female NZB/NZW F1 hybrids (24 ng/ml) was significantly lower then in control mice (521 ng/ml). The RED method was used to measure the concentration of actin as the DNase inhibitor in serum. G-actin in the presence of ATP binds DNase and inhibits its nucleolytic activity. Since ATP is necessary for the actin inhibition of DNase I, this shows that there is actin as well as DNase I in the serum. Actin is not only ATP-dependent, but also heat-labile. Heating the sera for 10 min at 50 degrees C increases DNase activity. This is an alternative method for measuring the concentration of actin in the serum. An almost identical estimate of actin concentration in sera of normal mice was found from the difference of DNase activity in the presence or absence of ATP (mean actin concentration = 21 ng/ml) or from the difference of DNase activity in heated and non-heated serum (mean actin concentration 18 ng/ml). We were not able to demonstrate DNase inhibitors in the urine of either control or NZB/W F1 hybrid mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9158089      PMCID: PMC1904653          DOI: 10.1046/j.1365-2249.1997.3571249.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

Review 1.  Defects in the disposal of dying cells lead to autoimmunity.

Authors:  Udo S Gaipl; Sandra Franz; Reinhard E Voll; Ahmed Sheriff; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

2.  Acquired loss of renal nuclease activity is restricted to DNaseI and is an organ-selective feature in murine lupus nephritis.

Authors:  Natalya Seredkina; Ole P Rekvig
Journal:  Am J Pathol       Date:  2011-06-30       Impact factor: 4.307

Review 3.  Autoimmunity: homeostasis of innate immunity gone awry.

Authors:  Hyon Ju Park; John P Atkinson
Journal:  J Clin Immunol       Date:  2012-10-11       Impact factor: 8.317

4.  Controlling DNA-nanoparticle serum interactions.

Authors:  Kyryl Zagorovsky; Leo Y T Chou; Warren C W Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

5.  Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications.

Authors:  S Zhang; X Shu; X Tian; F Chen; X Lu; G Wang
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  Circulating cell-free DNA concentration and DNase I activity of peripheral blood plasma change in case of pregnancy with intrauterine growth restriction compared to normal pregnancy.

Authors:  Elizaveta Ershova; Vasilina Sergeeva; Maria Klimenko; Kristina Avetisova; Peter Klimenko; Edmund Kostyuk; Natalia Veiko; Roman Veiko; Vera Izevskaya; Sergey Kutsev; Svetlana Kostyuk
Journal:  Biomed Rep       Date:  2017-08-17

7.  Optimizing Nanoparticle Design for Gene Therapy: Protection of Oligonucleotides from Degradation Without Impeding Release of Cargo.

Authors:  Oksana Fihurka; Juan Sanchez-Ramos; Vasyl Sava
Journal:  Nanomed Nanosci Res       Date:  2018-11-23

8.  Dnase1l3 deficiency in lupus-prone MRL and NZB/W F1 mice.

Authors:  A Wilber; T P O'Connor; M L Lu; A Karimi; M C Schneider
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

9.  Pharmacodynamics of recombinant human DNase I in serum.

Authors:  W S Prince; D L Baker; A H Dodge; A E Ahmed; R W Chestnut; D V Sinicropi
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

Review 10.  The Role of Anti-DNA Antibodies in the Development of Lupus Nephritis: A Complementary, or Alternative, Viewpoint?

Authors:  Beatrice Goilav; Chaim Putterman
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.